Ann: Annual Report to shareholders, page-4

Theres alway those over achievers that used to annoy you or make you envious at school, and then there's one RH that must do the same to the one said over achievers, very impressive academic

What a great asset this man is to the company, and would be to alot of companies, we're so fortunate to have him on board.

Name:
Dr Rohan Hockings M.B.B.S (Hons.), J.D.,
G.D.L.P
Title:
Executive Director & Chief Executive Officer –
Appointed 30 November 2018
Experience and expertise:
Dr Hockings spent four years with McKinsey
& Company and a further two years in the
Private Equity industry before joining PYC
Therapeutics. He brings a deep affinity for
conceptual thinking to PYC Therapeutics
along with an understanding of the company’s
technology and its commercialisation path.
Dr Hockings is a founding principal of a private
equity fund active in the acquisition of health
care assets within Australia. His previous roles
include strategy and operational advisory
positions with a global management consulting
firm, equity capital markets experience as a
solicitor with a national law firm and a number
of appointments as a medical practitioner. Dr
Hockings has a special interest in both venture
capital and private equity within the healthcare
industry.
Dr Hockings holds double degrees in medicine
and law. He has worked across both disciplines
following an internship at Sir Charles Gairdner
Hospital and admission to practice in the
Supreme Court of Victoria respectively.